Concepedia

Lijun Tao

LT

Statistics

Publications

4

Citations

147

H-Index

4

Active since

2017

Affiliations

China Pharmaceutical University(Current)

Lijun Tao is an author at China Pharmaceutical University specializing in inflammatory lung disease, medicine, and immunology.

Top concepts

MedicineImmunologyInflammationLung InflammationInflammatory Lung DiseaseCell BiologyPharmacologyCell SignalingOxidative StressAcute Lung Injury

Publications per year

2017–2017

4

Publications

4

Mogroside IIIE Attenuates LPS‐Induced Acute Lung Injury in Mice Partly Through Regulation of the TLR4/MAPK/NF‐κB Axis via AMPK Activation

Lijun Tao, Fengyan Cao, Gonghao Xu et al. · Phytotherapy Research · 2017 · 62 citations

Acute Lung Injury, Inflammatory Lung Disease, Lung Inflammation +23

Mogroside IIIE, a Novel Anti-Fibrotic Compound, Reduces Pulmonary Fibrosis through Toll-Like Receptor 4 Pathways

Lijun Tao, Jinyu Yang, Fengyan Cao et al. · Journal of Pharmacology and Experimental Therapeutics · 2017 · 45 citations

Protective role of rhapontin in experimental pulmonary fibrosis in vitro and in vivo

Lijun Tao, Juan Cao, Wencheng Wei et al. · International Immunopharmacology · 2017 · 27 citations

Inflammation, Fibrosis, Antifibrotic Therapy +14

An Active Drimane-Type Lactone from Polygonum jucundum Attenuates Lipopolysaccharide-Induced Acute Lung Injury in Mice Through TLR4-MAPKs Signaling Pathway

Yang Hu, Lijun Tao, Hui Ling Tan et al. · Inflammation · 2017 · 13 citations

Inflammation, Acute Lung Injury, Anti-inflammatory +12

1–4 of 4